Printer-friendly copy Email this topic to a friend
Lobby General Discussion topic #13180969

Subject: "Ghostface gets the last laugh." Previous topic | Next topic
Numba_33
Charter member
19335 posts
Fri Aug-04-17 02:30 PM

Click to send email to this author Click to send private message to this authorClick to view this author's profileClick to add this author to your buddy list
"Ghostface gets the last laugh."


  

          

I do wonder what'll happen to that Wu album Shkreli bought though.

link: https://www.yahoo.com/news/martin-shkreli-found-guilty-fraud-185643374.html

swipe:


Martin Shkreli found guilty of fraud by jury in New York

Joanna Walters in New York
The GuardianAugust 4, 2017


Martin Shkreli, the hedge fund manager turned pharmaceutical entrepreneur once dubbed “the most hated man in America” has been found guilty on three of eight federal charges that he deceived investors in a pair of failed hedge funds.

The jury of seven women and five men reached their verdict on the fifth day of deliberations after a month-long trial. Shkreli, nicknamed “Pharma Bro” for his troll-like behaviour, faced up to 20 years behind bars on the charges of securities fraud, conspiracy to commit securities fraud and conspiracy to commit wire fraud.

Shkreli achieved notoriety in 2015 after the 34-year-old increased the price of a life-saving drug, Daraprim, used by people with Aids and others suffering from toxoplasmosis, by 5,000% overnight, shortly after his pharmaceutical startup bought the commercial rights to it.

The move led to BBC calling him America’s most hated man. Even Donald Trump weighed in, calling Shkreli a “spoiled brat” and his business practices “disgusting”.

Seeming to revel in his notoriety, Shkreli doubled down telling The Guardian: “There are very few people who care about toxoplasmosis more than me.” He reinforced his notoriety with a troll-like internet presence, especially towards female journalists and celebrities.

But the drug pricing scandal is not why he was on trial. Shkreli was arrested in December 2015 in a early morning raid and led away in handcuffs, accused of lying to investors after making poor bets on the stock market via his hedge funds and then illegally paying people back in cash and stock from pharmaceutical businesses he had created. According to prosecutors, he was running a form of pyramid, or Ponzi, scheme.

Shkreli’s provocative posturing was on full display during his four weeks of testimony in July, 2017, at his trial in federal court in Brooklyn, New York.

Judge Kiyo Matsumoto ordered Shkreli to stop commenting on the trial during the early days of the hearing after he called prosecutors “junior varsity” and said people “blame me for everything” in a rant to reporters.

He was barred from Twitter after harassing a female reporter but appears to have come back with several aliases. The latest, @SamTheManTP, appeared irritated with delay in the verdict, tweeting: “Cmon gimme dat verdict”, and “yeah I’m innocent stupid.” On Thursday, @SamTheManTP tweeted: “Trump has been flawless since election. Not one mistake made, pretty amazing. #flawless”

At the trial, his high profile lawyer, Benjamin Brafman, who successfully defended former International Monetary Fund boss Dominique Strauss-Kahn in a sexual assault case, claimed Shkreli merely made some honest mistakes and was doing business with the best of intentions. His client was “a genius” who reimbursed his investors and made many of them very rich.

Shkreli denied all counts and, echoing Trump’s opinion of the Department of Justice and congressional Russia investigations, has called the case a witch-hunt.

Witch-hunt or not, Shkreli did little to appease his persecutors. Even while awaiting his fate from the jury, he continued to provoke via Facebook, including giving out stock market advice and taking a jab at the freshly-fired White House communications director Anthony Scaramucci.

Presenting Shkreli’s defense in court, Brafman tried to humanize his client. While attending Hunter College High in New York – a school for intellectually gifted children – his client was bullied and was known for being nerdy and extremely socially awkward, and had a tendency to be manipulated, said Brafman.

One trial witness last month, Schuyler Marshall, a Dallas-based real estate company chairman who invested in one of Shkreli’s later hedge funds, said that Shkreli reminded him of the film character Rain Man, the autistic savant played by Dustin Hoffman, who has extraordinary mathematical powers but difficulty relating to others.

Under cross-examination, Marshall said that he was not claiming Shkreli was autistic, but that: “The reference here was that this was just an intensely focused, bright guy who knew his stuff.”

Jurors also heard that a former employee, Caroline Stewart, chatting online with a co-worker in 2011, said that Shkreli was mentally unstable and a scam artist, who kept deceiving her over money he owed her and was lying repeatedly to investors, employees and investigators.

“I’m done trusting Martin, I can’t believe a word that comes out of his mouth,” the court heard she wrote of Shkreli.

“What do you say to a guy who shoots off at the mouth and has no intention of delivering? He’s a scam artist ... I can’t deal with somebody who lies all the time.”

Shkreli’s self-image as a genius investor has also taken a beating at the trial. The two other hedge funds and a pharmaceutical company called Retrophin he created all spiraled towards collapse. After making risky bets of the markets Shkreli risked ruin and, in December 2012, was down to his last $1,415, according to the New York Times.

In a burst of frenetic communications with investors, employees and advisers, he ultimately managed to raise fresh capital for Retrophin and save it from the brink. He was later ousted from Retrophin. Now a public company, it has since achieved financial success, and some of his earlier investors who were being given the runaround by Shkreli made huge profits because he gave them Retrophin stock.

Prosecutors argued Shkreli illegally used Retrophin assets to pay back the investors from his busted hedge funds.

After leaving Retrophin, he started another biotech company, Turing Pharmaceuticals, and it was this firm that bought the rights to the drug Daraprim in August 2015, hiking the price and making headlines in September 2015.

He was later forced out of that company, too.

While always having plenty to say online, Shkreli refused to testify at a congressional hearing on drug pricing in 2016, deploying little more than his smirk.

"Sean sparks like John Starks, nah, Sean ball like John Wall" - Rest In Power Forever Sean Price.

  

Printer-friendly copy | Reply | Reply with quote


Ghostface gets the last laugh. [View all] , Numba_33, Fri Aug-04-17 02:30 PM
 
Subject Author Message Date ID
what happens now with the epi pens
Aug 04th 2017
1
^^^
Aug 04th 2017
2
They go back to overcharging like providing stakeholder value like every...
Aug 05th 2017
3
epi pens was a different Corp douche
Aug 06th 2017
6
NYT: Outcry Over EpiPen Prices Hasn’t Made Them Lower (swipe)
Aug 06th 2017
7
thought this was about Action Bronson
Aug 05th 2017
4
me too
Aug 05th 2017
5

Lobby General Discussion topic #13180969 Previous topic | Next topic
Powered by DCForum+ Version 1.25
Copyright © DCScripts.com